Morgan Stanley
ONCO icon

Morgan Stanley’s Onconetix ONCO Stock Holding History

Morgan Stanley’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24 Buy
+21
New +$96 ﹤0.01% 8274
2025
Q3 		– Sell
-116
Closed -$27.7K – 8305
2025
Q2 		$27.7K Buy
+116
New +$34.1K ﹤0.01% 6541
2025
Q1 		– Hold
0
– – – 8057
2022
Q2 		– Hold
0
– -$25K – 7924
2022
Q1 		– Hold
0
– – – 7045

Other funds holding ONCO

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Morgan Stanley's ONCO Position: Q2 2026 in Review

Morgan Stanley opened a new position in Onconetix (ONCO) in Q2 2026: 21 shares worth $24. The stake represents ﹤0.01% of the portfolio and ranks #8274 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in ONCO as recently as Q2 2025.

Morgan Stanley first reported a position in ONCO in Q2 2025 and has held it in 2 quarters since. The position peaked at $27.7K in Q2 2025. 6 funds tracked by Wall St. Rank hold ONCO as of Q2 2026.

  • Morgan Stanley held 21 shares of Onconetix worth $24 as of Q2 2026.
  • Onconetix was a new Morgan Stanley position in Q2 2026.
  • Onconetix made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8274 holding.
  • Morgan Stanley first reported a position in Onconetix in Q2 2025 and has held it in 2 quarters since.
  • Morgan Stanley's Onconetix position peaked at $27.7K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Onconetix as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.